Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza viruses - Wikidata - wikimedia - TriplyDB

Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza viruses

Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza viruses

http://www.wikidata.org/entity/Q34737817

about

Novel approaches and challenges to treatment of central nervous system viral infections Humanized antibody neutralizing 2009 pandemic H1N1 virus.Passive broad-spectrum influenza immunoprophylaxis In vivo time-related evaluation of a therapeutic neutralization monoclonal antibody against lethal enterovirus 71 infection in a mouse model.Extent of antigenic cross-reactivity among highly pathogenic H5N1 influenza viruses Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rγc KO. NOD).

P2860

Q26862449-860A5D52-DFA9-4FB4-9527-A3421963F494 Q30364911-23ABAE15-76E3-494D-AE2C-AE9C03AAED5E Q30367936-65210E1C-6AC6-4DF9-A579-8BF4CE77916B Q34287387-4C389B0B-1299-4E69-AAE1-824D487459E2 Q35273724-FAE262B4-F4AC-49D7-8BAB-8D60615A22F3 Q47405444-19625E3A-E88C-4F4F-A748-3A41521DFBF1

P2860

Properties and therapeutic efficacy of broadly reactive chimeric and humanized H5-specific monoclonal antibodies against H5N1 influenza viruses

http://www.wikidata.org/entity/Q34737817

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Properties and therapeutic eff ...... against H5N1 influenza viruses

@ast

Properties and therapeutic eff ...... against H5N1 influenza viruses

@en

Properties and therapeutic eff ...... against H5N1 influenza viruses

@nl

type

label

Properties and therapeutic eff ...... against H5N1 influenza viruses

@ast

Properties and therapeutic eff ...... against H5N1 influenza viruses

@en

Properties and therapeutic eff ...... against H5N1 influenza viruses

@nl

prefLabel

Properties and therapeutic eff ...... against H5N1 influenza viruses

@ast

Properties and therapeutic eff ...... against H5N1 influenza viruses

@en

Properties and therapeutic eff ...... against H5N1 influenza viruses

@nl

P1433

Q34737817-E0786B09-2868-4BC8-978E-BD02F06312A4

P1476

Q34737817-CE94D82E-1994-4255-95FB-844FB6C8CB24

P2093

Q34737817-0ECD027C-D803-4602-B373-93FEB8D3AEBC

Q34737817-1DFBF2D6-195C-4558-B6FB-BE05F66A25C4

Q34737817-2F989BAB-3C9D-49DB-8392-3320F5947D1A

Q34737817-366C8544-124F-4B3E-B442-2F4138BAEF0C

Q34737817-4F448719-088B-4D64-878E-847604FA037F

Q34737817-5DFFD017-F11A-4943-985B-73FCCD6AB023

Q34737817-79F20A18-A3F2-4961-8131-E89D6F1C2C38

Q34737817-9F278615-A198-44D1-8162-A1390EC57132

Q34737817-C52C393E-F084-4AF7-B4F0-A080A550C17F

Q34737817-DF9F4815-72AD-47E5-8299-A411373CBB0A

P2860

Q34737817-01B26B11-12FA-4AEB-816F-4E6F2073143B

Q34737817-028A3DE5-CECF-43DE-8948-399EE8FB62BC

Q34737817-06017710-152A-4C7C-B697-16616B890D2D

Q34737817-0E13C256-B369-4245-A22E-FF3CDFF5577A

Q34737817-101F9C19-1474-474B-B603-B5A4D20C0ABD

Q34737817-151EA365-5447-4063-8E4A-A5481BD0A56F

Q34737817-2ACDA068-92CD-49D4-8BAB-A11E743102E4

Q34737817-37B8EDD9-5362-47D3-B601-3D10B8CCE0FC

Q34737817-43611495-F154-4573-9841-205CA78AE5E0

Q34737817-555DDA12-84B4-4B7B-B6B4-056BE4D63E35

P304

Q34737817-D0CEADE6-16A1-4195-930F-3999478784F0

P31

Q34737817-761DDF10-7567-4589-86AC-EBEDFBA10F95

P356

Q34737817-FBC7E1A4-B89E-4054-84B5-98199BB9A7AF

P407

Q34737817-31140707-7876-46F6-85F3-9AC2870FAA65

P433

Q34737817-F8075710-B303-473D-A5C2-CF49F6838A6F

P478

Q34737817-82AFFB95-6E27-44B6-BDEF-38605E355AFB

P577

Q34737817-0F4EC6FF-909A-41E6-86C0-9499A21D6684

P698

Q34737817-74251220-D967-40F6-A099-3B1389A79A95

P921

Q34737817-F0C99D6C-30C1-4416-AEFE-6D97B528560F

P932

Q34737817-BBBE58C2-1EED-44CC-AE80-917A5DB36F68

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Properties and therapeutic eff ...... against H5N1 influenza viruses

@en

P2093

Hai Yu

http://www.w3.org/2001/XMLSchema#string

Honglin Chen

http://www.w3.org/2001/XMLSchema#string

Jun Wu

http://www.w3.org/2001/XMLSchema#string

Lin Xia

http://www.w3.org/2001/XMLSchema#string

Ningshao Xia

http://www.w3.org/2001/XMLSchema#string

Qingbing Zheng

http://www.w3.org/2001/XMLSchema#string

Siu-Ying Lau

http://www.w3.org/2001/XMLSchema#string

Wai Lan Wu

http://www.w3.org/2001/XMLSchema#string

Wenxin Luo

http://www.w3.org/2001/XMLSchema#string

Yanning Liu

http://www.w3.org/2001/XMLSchema#string

P2860

New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

Mechanism of drug inhibition and drug resistance of influenza A M2 channel

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

Update on avian influenza A (H5N1) virus infection in humans

Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza

Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control

P304

1349-1357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01436-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21245446

http://www.w3.org/2001/XMLSchema#string

P921

P932

3067186

http://www.w3.org/2001/XMLSchema#string